secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0001104659-21-152914
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders re-elect all five directors and approve 1.52M share increase to incentive plan at 2021 annual meeting
--------------------------------------------------------------------------------

- All five director nominees (Shulman, Silverman, Bernstein, Bradley, Walker) re-elected with >99% votes cast in favor.
- Second Amendment to 2020 Omnibus Incentive Plan approved (5.86M for, 85K against), increasing shares reserved to 2.6M.
- EisnerAmper LLP ratified as independent auditor for FY2021 with 9.18M votes for, 36.8K against.
- Advisory say-on-pay passed with 5.89M for (98.9% of votes cast); shareholders chose 1-year frequency for future votes.
- Voter turnout: 9.23M of total voting power; broker non-votes of ~3.26M on most proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921152914/0001104659-21-152914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921152914/tm2136177d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-152914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer